Mereo BioPharma Group plc
MREO
$2.17
-$0.08-3.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.03% | -24.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.75% | -6.93% | |||
| Operating Income | -1.18% | 11.46% | |||
| Income Before Tax | 51.94% | -13.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 51.94% | -13.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 51.94% | -13.42% | |||
| EBIT | -1.18% | 11.46% | |||
| EBITDA | -2.32% | 11.78% | |||
| EPS Basic | 51.97% | -11.19% | |||
| Normalized Basic EPS | 49.91% | -11.31% | |||
| EPS Diluted | 51.97% | -11.19% | |||
| Normalized Diluted EPS | 49.91% | -11.31% | |||
| Average Basic Shares Outstanding | 0.06% | 1.93% | |||
| Average Diluted Shares Outstanding | 0.06% | 1.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||